BA
The Boeing Company
BA has the edge over DLHC overall, supported by stronger fundamentals.
DLHC
DLH Holdings Corp.
DLHC trails on the overall score without a compensating advantage in the available component scores.
BA Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Stable | |
| Under pressure |
BA's profitability is currently healthy, and its revenue and cash flow are stable, but its balance sheet is under pressure.
DLHC Fundamentals
| Metric | Status |
|---|---|
| Weak | |
| Under pressure | |
| Stable | |
| Weak |
DLHC's cash flow is currently stable, but its revenue, profitability and balance sheet are under pressure.
BA PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 18x | $172 | — |
| Cheap | 51x | $496 | +189% |
| Fair | 82x | $790 | +360% |
| Expensive | 91x | $876 | +411% |
Historical ranges are pointers, not guarantees.
BA's PE is 18x, but its earnings don't support one, so it isn't a reliable read right now.
DLHC PE Valuation
DLHC has no meaningful PE right now: it lost money over the past year.
BA Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Returning to profit | |
| Growth | |
| Improving | |
| Limited | |
| Low |
Analysts expect BA to return to profit, with revenue growing. However, they disagree widely on these estimates.
DLHC Forward outlook
There aren't enough analyst estimates for DLHC to show an outlook.
BA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | $9.66 | +$23.38 |
| Q2 2026 | $2.78 | +$19.33 |
| Q1 2026 | $2.53 | +$20.49 |
| Q4 2025 | $2.48 | +$20.84 |
| Q3 2025 | -$13.72 | -$0.83 |
| Q2 2025 | -$16.55 | -$10.93 |
| Q1 2025 | -$17.96 | -$14.42 |
| Q4 2024 | -$18.36 | -$14.69 |
BA has the edge over DLHC on earnings quality, reporting a profit while its opponent remains loss making.
DLHC Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | -$1.48 | -563% |
| Q1 2026 | -$0.30 | -179% |
| Q4 2025 | -$0.07 | -116% |
| Q3 2025 | $0.10 | -80% |
| Q2 2025 | $0.32 | +88% |
| Q1 2025 | $0.38 | +81% |
| Q4 2024 | $0.44 | +214% |
| Q3 2024 | $0.51 | +410% |
DLHC has swung to a loss: it lost $1.48 per share over the past year, after a profit the year before.
BA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $24.2B | +3.9% |
| Q2 2026 | $24.6B | +8% |
| Q1 2026 | $22.2B | +14% |
| Q4 2025 | $23.9B | +57% |
| Q3 2025 | $23.3B | +30% |
| Q2 2025 | $22.7B | +35% |
| Q1 2025 | $19.5B | +18% |
| Q4 2024 | $15.2B | -31% |
BA has the edge over DLHC on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 1.5% | +22 points |
| Q2 2026 | 0.6% | +1.4 points |
| Q1 2026 | 2% | -0.3 points |
| Q4 2025 | 37% | +61 points |
| Q3 2025 | -21% | +12 points |
| Q2 2025 | -0.8% | +5.7 points |
| Q1 2025 | 2.4% | +2.9 points |
| Q4 2024 | -25% | -26 points |
BA has the edge over DLHC on profitability, with a higher operating margin.
DLHC Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $44.2M | -47% |
| Q1 2026 | $59.3M | -34% |
| Q4 2025 | $68.9M | -24% |
| Q3 2025 | $81.2M | -16% |
| Q2 2025 | $83.3M | -17% |
| Q1 2025 | $89.2M | -12% |
| Q4 2024 | $90.8M | -7.2% |
| Q3 2024 | $96.4M | -5% |
DLHC's revenue has slid since its 2021 peak: $44M last quarter, down 47% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | -8.9% | -13 points |
| Q1 2026 | -0.1% | -5.8 points |
| Q4 2025 | 2.1% | -4.1 points |
| Q3 2025 | 2.8% | -3.8 points |
| Q2 2025 | 4.5% | -1.2 points |
| Q1 2025 | 5.7% | -0.1 points |
| Q4 2024 | 6.2% | -0.8 points |
| Q3 2024 | 6.6% | +6.5 points |
DLHC's operating margin was −8.9% last quarter, down 13 points from the same quarter a year ago, near the bottom of its range since 2019.
BA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $464M | +95% |
| Q2 2026 | $631M | +$831M |
| Q1 2026 | -$1.5B | +$836M |
| Q4 2025 | $375M | +$4.5B |
| Q3 2025 | $238M | +$2.2B |
| Q2 2025 | -$200M | +$4.1B |
| Q1 2025 | -$2.3B | +$1.6B |
| Q4 2024 | -$4.1B | -239% |
BA has the edge over DLHC on cash flow, with more consistent year-over-year improvement.
DLHC Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $4.2M | -55% |
| Q1 2026 | $3.8M | -75% |
| Q4 2025 | -$4.8M | +$7.3M |
| Q3 2025 | $10.7M | -13% |
| Q2 2025 | $9.4M | +109% |
| Q1 2025 | $15.1M | +205% |
| Q4 2024 | -$12.1M | -347% |
| Q3 2024 | $12.2M | -24% |
DLHC still generates free cash flow, though less than at its 2021 peak: $14M over the past year.
BA Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.3% | +2.1M shares |
| 1 year | +4.3% | +32.8M shares |
| 3 years | +31% | +186M shares |
| 5 years | +35% | +204M shares |
| Available history | +40% | +227M shares |
BA has 793M diluted shares, up 4.3% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2019 | — |
DLHC Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | -- |
| 1 year | +0.3% | +43K shares |
| 3 years | +4.3% | +593K shares |
| 5 years | +6.1% | +838K shares |
| Available history | +11% | +1.5M shares |
DLHC has the edge over BA on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q1 2023 | — |
| Q3 2021 | — |
| Q2 2021 | — |
| Q1 2021 | — |
| Q4 2020 | — |
| Q3 2020 | — |
| Q2 2020 | — |
| Q1 2020 | $5,000 |
BA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 3.0x | Elevated |
| Q2 2026 | 5.7x | High |
| Q1 2026 | 6.0x | High |
| Q4 2025 | 6.9x | High |
| Q2 2024 | 361.8x | High |
| Q1 2024 | 36.1x | High |
| Q4 2023 | 36.4x | High |
| Q3 2023 | 96.1x | High |
BA has the edge over DLHC on leverage, with a lower net debt burden relative to earnings.
DLHC Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | 7.6x | High |
| Q1 2026 | 5.3x | High |
| Q4 2025 | 4.5x | High |
| Q3 2025 | 3.8x | Elevated |
| Q2 2025 | 3.6x | Elevated |
| Q1 2025 | 3.7x | Elevated |
| Q4 2024 | 4.0x | Elevated |
| Q3 2024 | 3.6x | Elevated |
DLHC's net debt is about 7.6 years of its operating earnings (EBITDA), up from 3.6 years a year ago.
BA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 31.1 | Neutral |
| Stochastic | 9.6 | Oversold |
BA's weekly RSI is 31 (neutral) and its Stochastic is 10 (oversold).
DLHC Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 31.0 | Neutral |
| Stochastic | 11.3 | Oversold |
DLHC's weekly RSI is 31 (neutral) and its Stochastic is 11 (oversold).
BA PE vs Industrials Sector
| Metric | BA | Sector median | Relative |
|---|---|---|---|
| PE | 18x | 24x | 26% below |
| PE % | 0 | 58 | 58 pts below |
BA is trading at 18x earnings, a 26% discount to the Industrials sector's median of 24x, though its earnings don't support one.
DLHC PE vs Industrials Sector
| Metric | DLHC | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 24x | — |
DLHC has no meaningful PE right now: it lost money over the past year.
BA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $184.6 | 7.1% below |
| 20 week MA | $203.8 | 16% below |
| 50 week MA | $215.5 | 20% below |
| 100 week MA | $205.9 | 17% below |
| 200 week MA | $200.6 | 14% below |
BA is in a downtrend: it's below all five of its weekly moving averages, and 14% below its 200-week average.
DLHC Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $3.80 | 7.9% below |
| 20 week MA | $4.32 | 19% below |
| 50 week MA | $5.17 | 32% below |
| 100 week MA | $5.39 | 35% below |
| 200 week MA | $8.53 | 59% below |
DLHC is in a downtrend: it's below all five of its weekly moving averages, and 59% below its 200-week average.
BA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $330.1 | $217.2 | -34% |
| 2021 | $217.2 | $204.2 | -6% |
| 2022 | $204.2 | $189.1 | -7.4% |
| 2023 | $189.1 | $260.7 | +38% |
| 2024 | $260.7 | $180.7 | -31% |
| 2025 | $180.7 | $216.4 | +20% |
| 2026 YTD | $216.4 | $171.6 | -21% |
BA has the edge over DLHC on returns for 2026, with the stronger performance.
DLHC Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $4.12 | $9.15 | +122% |
| 2021 | $9.15 | $18.0 | +97% |
| 2022 | $18.0 | $12.5 | -30% |
| 2023 | $12.5 | $15.8 | +26% |
| 2024 | $15.8 | $7.63 | -52% |
| 2025 | $7.63 | $5.65 | -26% |
| 2026 YTD | $5.65 | $3.50 | -38% |
DLHC's yearly returns have swung widely, from +122% in 2020 to −52% in 2024. It's down 38% so far in 2026.